» Articles » PMID: 15851908

Risk Factors for HIV Infection in Injection Drug Users and Evidence for Onward Transmission of HIV to Their Sexual Partners in Chennai, India

Overview
Date 2005 Apr 27
PMID 15851908
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Determining HIV prevalence in injection drug users (IDUs) and their regular sex partners in Chennai, India.

Methods: A total of 226 IDUs and their regular sex partners were enrolled during April-July 2003. After informed consent was obtained, a semistructured questionnaire was administered and serum was tested for HIV antibody.

Results: The HIV seroprevalence was 30% (68/226) in IDUs and 5% in their regular sex partners (11/226). While in 25% of couples only the male partner was HIV positive, 5% of the couples were concordant for HIV infection and 70% were HIV negative. Fifty-seven percent of the HIV-positive IDUs and 45% of the HIV-infected women thought that they had "no chance" or "very little chance" of getting HIV, reflecting low HIV risk perception. More than 20% IDUs reported borrowing or lending of injection equipment. In univariate analyses "sex" and "condom use" with sex workers had no bearing but "more than twice a day injecting frequency," "history of incarceration," "tattoos," "recruitment from northern part of the city," and ever-injecting drugs in drug-selling places had significant association with HIV infection in IDUs. In an adjusted model, the odds of HIV infection were 2 times higher among IDUs who had ever injected drugs in drug-selling places and 6 times higher in those who were recruited from the northern part of central Chennai.

Conclusion: Reducing sharing of injection equipment and unsafe tattooing through targeted and environmental interventions, increasing HIV risk perception, and promoting safer sex practices among IDUs and their sex partners are urgent program needs.

Citing Articles

HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.

Shukla L, Shivaprakash P, Suresh Kumar M Indian J Med Res. 2024; 158(5&6):522-534.

PMID: 38265946 PMC: 10878493. DOI: 10.4103/ijmr.ijmr_1930_23.


Changes in and Predictors of HIV among People Who Inject Drugs in Mizoram, Northeast India, from 2007 to 2021.

Pachuau L, Tannous C, Chawngthu R, Agho K Int J Environ Res Public Health. 2023; 20(10).

PMID: 37239596 PMC: 10217957. DOI: 10.3390/ijerph20105871.


HIV and its associated factors among people who inject drugs in Mizoram, Northeast India.

Pachuau L, Tannous C, Chawngthu R, Agho K PLoS One. 2023; 18(5):e0286009.

PMID: 37216389 PMC: 10202280. DOI: 10.1371/journal.pone.0286009.


HIV among people who inject drugs in India: a systematic review.

Pachuau L, Tannous C, Dhami M, Agho K BMC Public Health. 2022; 22(1):1529.

PMID: 35948967 PMC: 9367073. DOI: 10.1186/s12889-022-13922-2.


Analysis of a Targeted Intervention Programme on the Risk Behaviours of Injecting Drug Users in India: Evidence From the National Integrated Biological and Behavioural Surveillance Survey.

Sahu D, Ranjan V, Chandra N, Nair S, Kumar A, Arumugam E J Prev Med Public Health. 2022; 55(4):407-413.

PMID: 35940196 PMC: 9371777. DOI: 10.3961/jpmph.22.150.